Dentalcare logo

Laser Therapy for Adjunctive Treatment of Peri-Implant Disease

COURSE NUMBER: 564

Maria L. Geisinger, DDS, MS

Credit Hours:

2 Hour(s)

PDF

This course seeks to evaluate the use of laser therapy as an adjunctive means of implant surface detoxification in conjunction with surgical and non-surgical therapies.


The placement of endosseous dental implants is a well-accepted treatme...

View More

(Use this feature to create assignments for your students and staff.)

Overview

This course seeks to evaluate the use of laser therapy as an adjunctive means of implant surface detoxification in conjunction with surgical and non-surgical therapies.


The placement of endosseous dental implants is a well-accepted treatment option for edentulism as implants have demonstrated high survival rates over long periods of time.1 Dental implants are a common and growing treatment modality and it is estimated that up to 5 million dental implants are placed each year.2 While dental implant survival rates remain high, reports indicate that a significant proportion of dental implants will develop peri-implant mucositis and peri-implantitis.3-6 Inflammatory implant diseases are progressive and it has been shown that the inflammatory lesions associated with peri-implant diseases are larger than those around teeth with similar clinical presentation.7-8 There are several risk factors that can lead to inflammation, peri-implant mucositis, and, later, peri-implantitis.4,9-11 Systemic and environmental factors may play a secondary role in disease progression and susceptibility, but peri-implant diseases are initiated by accumulation of bacterial biofilm.4,12,13 As bacterial plaque is the primary etiology for peri-implant disease, current therapies for peri-implantitis focus upon dental plaque removal and implant surface detoxification as a critical step to surgical and/or nonsurgical treatment of peri-implantitis.14,15, This surface detoxification has been accomplished with physical, chemical, and/or other means, including laser therapy. A variety of laser types have been used for implant surface detoxification including: Er:YAG, Nd;YAG, carbon dioxide, diode lasers, and photodynamic therapy.14,16,17, As of yet, there are no definitive data on superiority of laser type or treatment modality in conjunction with either surgical or nonsurgical therapy.18-20,


Additionally, a recent consensus statement from the American Academy of Periodontology confirmed evidence for limited, short-term benefits to adjunctive laser use for peri-implant lesions, but no current definitive evidence regarding the long-term efficacy of this type of therapy.21, At present, there is insufficient evidence for the use of lasers of any type used as a monotherapy for the surgical or nonsurgical treatment of peri-implantitis.21,22, As the number of endosseous dental implants placed continues to increase, the cumulative incidence of peri-implantitis is also increasing.

  • Intended Audience:

    Dentists, Dental Hygienists, Dental Students, Dental Hygiene Students

  • Date Course Online:

    Feb 1, 2019

  • Last Revision Date:

    Feb 8, 2022

  • Course Expiration Date:

    Feb 7, 2025

  • Cost:

    Free

  • Method:

    Self-instructional

  • AGD Subject Code(s):

    135, 10, 690

Learning Objectives

Upon the completion of this course, the dental professional should be able to:


  • Understand the current scientific literature about the prevalence, etiology, and stages of peri-implant diseases.
  • Recognize, assess, and develop treatment and preventative strategies for peri-implant diseases.
  • Evaluate the available evidence regarding the efficacy of adjunctive laser therapy in combination with surgical and nonsurgical treatment modalities for peri-implant disease and choose the appropriate treatment based upon the patient’s presentation.
  • Discuss risks, benefits and therapeutic options with patients prior to implant therapy or with peri-implant diseases.

Disclaimers

P&G is providing these resource materials to dental professionals. We do not own this content nor are we responsible for any material herein.


Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice.  Only sound evidence-based dentistry should be used in patient therapy.


Note:  Registration is required to take test.

Author(s)

Conflict of Interest Disclosure Statement

  • Dr. Geisinger does not have any conflicts of interest in regard to the topic of this course. She has no relevant financial relationships to disclose.
Maria L. Geisinger

Maria L. Geisinger

DDS, MS

Mia L. Geisinger, DDS, MS is a Professor and Director of Advanced Education in Periodontology in the Department of Periodontology in the University of Alabama at Birmingham (UAB) School of Dentistry. Dr. Geisinger received her BS in Biology ...

View More

Submission Information

Academy of General Dentistry (AGD) Submission For credit transfers to appear in your AGD account in real time, make sure to add your AGD membership number in the field provided on the “Share Your Test Score” page.


CE Broker For all states that use CE Broker for licensure, “proof of completions” are electronically reported the first of every month. If a course was taken in November, the “proof of completion” will be submitted the beginning of December.

Recognition

ADA CERP Logo

ADA CERP Recognized Provider

The Procter & Gamble Company is an ADA CERP Recognized Provider.


ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.


Concerns or complaints about a dental CE provider may be directed to the provider or to ADA CERP at:


https://www.ada.org/en/ccepr/ada-cerp-recognition/complaints

AGD Pace Logo

Approved PACE Program Provider

THE PROCTER & GAMBLE COMPANY


Nationally Approved PACE Program Provider for FAGD/MAGD credit.

Approval does not imply acceptance by any regulatory authority or AGD endorsement.


8/1/2021 to 7/31/2027

Provider ID# 211886

AADH Logo

AADH Approved Program Provider

Procter & Gamble is designated as an approved Provider by the American Academy of Dental Hygiene, Inc. #AADHPGC (January 1, 2022-December 31, 2023). Approval does not imply acceptance by a state or provincial Board of Dentistry. Licensee should maintain this document in the event of an audit.